跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SLENYTO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SLENYTO
Authorized
STANDARD
SLENYTO
Neurim Pharmaceuticals Ltd.
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
275fa31043d0afe5
Company
Neurim Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
275fa31043d0afe5
Drug Approval Canada Name
SLENYTO
Product Name
SLENYTO
Status
Approved
Status Date
2025-09-08
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:24.48
Atc Original
N05CH01 MELATONIN
Aig Number
0119631004
Company Name
Neurim Pharmaceuticals Ltd.
Company Address
27 Habarzel St. Tel Aviv Israel 6971039
Company Detail Path
/organization/neurim-pharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
Neurim Pharmaceuticals Ltd.
Country Name
Israel
Website
http://www.neurim.com
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
275fa31043d0afe5
Type
Standard
Back to Health Canada Approvals